Trait centric view

1. Trait name:	Average daily gain
   Ontology terms:	VT:0001731, CMO:0000419

   64 genes are associated with this trait, with QTL/association found

   • ACAD11: Acyl-CoA dehydrogenase family, member 11
     evidenced by: QTL:154051; QTL:154053;
   • ADCYAP1: Adenylate cyclase activating polypeptide 1
     evidenced by: QTL:193794;
   • ATP6V1B2: ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2
     evidenced by: QTL:24267;
   • ATP6V1E2: ATPase H+ transporting V1 subunit E2
     evidenced by: QTL:153993;
   • CAST: Calpastatin
     evidenced by: QTL:153980; QTL:154058;
   • CCKBR: Cholecystokinin B receptor
     evidenced by: QTL:24259;
   • CCSER1: Family with sequence similarity 190, member A
     evidenced by: QTL:25113;
   • CIDEC: Cell death-inducing DFFA-like effector c
     evidenced by: QTL:57075;
   • CNGA3: Cyclic nucleotide gated channel alpha 3
     evidenced by: QTL:153990;
   • CNTFR: Ciliary neurotrophic factor receptor
     evidenced by: QTL:153988;
   • CRH: Corticotropin releasing hormone
     evidenced by: QTL:28723;
   • DPP6: Dipeptidyl-peptidase 6
     evidenced by: QTL:23219;
   • ELMOD1: ELMO/CED-12 domain containing 1
     evidenced by: QTL:23222;
   • EVC2: EvC ciliary complex subunit 2
     evidenced by: QTL:153975;
   • FASN: Fatty acid synthase
     evidenced by: QTL:19979;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:19974; QTL:19976;
   • GAD1: Glutamate decarboxylase 1 (brain, 67kDa)
     evidenced by: QTL:13206; QTL:13210; QTL:13214;
   • GH1: Growth hormone 1
     evidenced by: QTL:28700;
   • GHR: Growth hormone receptor
     evidenced by: QTL:18445; QTL:28705;
   • GHSR: Growth hormone secretagogue receptor
     evidenced by: QTL:18779; QTL:18783; QTL:18787;
   • HGF: Hepatocyte growth factor (hepapoietin A; scatter factor)
     evidenced by: QTL:25225; QTL:25226; QTL:25228;
   • HMCN1: Hemicentin 1
     evidenced by: QTL:154005; QTL:154006; QTL:154009; QTL:154010;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13106;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:18453;
   • ITFG1: Integrin alpha FG-GAP repeat containing 1
     evidenced by: QTL:180981;
   • KDELC2: KDEL (Lys-Asp-Glu-Leu) containing 2
     evidenced by: QTL:23223;
   • LCORL: Ligand dependent nuclear receptor corepressor-like
     evidenced by: QTL:20097; QTL:20099; QTL:20101;
   • LHFPL6: LHFPL tetraspan subfamily member 6
     evidenced by: QTL:167133;
   • LOC615217: Similar to cholecystokinin B receptor
     evidenced by: QTL:2639;
   • LRRIQ3: Leucine-rich repeats and IQ motif containing 3
     evidenced by: QTL:25111;
   • MC4R: Melanocortin 4 receptor
     evidenced by: QTL:28718;
   • MSTN: Myostatin
     evidenced by: QTL:11869;
   • NCAPG: Non-SMC condensin I complex, subunit G
     evidenced by: QTL:20086; QTL:20088; QTL:20089; QTL:20091; QTL:20093; QTL:20094; QTL:20095;
   • NCKAP5: NCK-associated protein 5
     evidenced by: QTL:23218;
   • NOP2: NOP2 nucleolar protein homolog (yeast)
     evidenced by: QTL:18434;
   • NPY: Neuropeptide Y
     evidenced by: QTL:18435; QTL:18436;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:13198; QTL:13202;
   • PAK1IP1: PAK1 interacting protein 1
     evidenced by: QTL:23225;
   • PDE4B: Phosphodiesterase 4B
     evidenced by: QTL:193795;
   • PHOX2A: Paired-like homeobox 2a
     evidenced by: QTL:23224;
   • PLAG1: Pleiomorphic adenoma gene 1
     evidenced by: QTL:20873;
   • POU1F1: POU class 1 homeobox 1
     evidenced by: QTL:28714;
   • PPM1K: Protein phosphatase, Mg2+/Mn2+ dependent 1K
     evidenced by: QTL:153966;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:11310; QTL:11312;
   • PRKAG3: Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
     evidenced by: QTL:28743;
   • PRLR: Prolactin receptor
     evidenced by: QTL:13130;
   • PRNP: Prion protein
     evidenced by: QTL:1392;
   • PROP1: PROP paired-like homeobox 1
     evidenced by: QTL:25370;
   • PTI: Pancreatic trypsin inhibitor
     evidenced by: QTL:24270;
   • RARRES2: Retinoic acid receptor responder (tazarotene induced) 2
     evidenced by: QTL:20670;
   • RLF: RLF zinc finger
     evidenced by: QTL:193783;
   • RPL26: Ribosomal protein L26
     evidenced by: QTL:180979;
   • SH2B2: SH2B adaptor protein 2
     evidenced by: QTL:25271; QTL:25276; QTL:25280;
   • SLC38A9: Solute carrier family 38 member 9
     evidenced by: QTL:193796;
   • SLC45A2: Solute carrier family 45, member 2
     evidenced by: QTL:154019; QTL:154020;
   • SMARCAL1: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
     evidenced by: QTL:153958; QTL:154055; QTL:154056;
   • SREBF1: Sterol regulatory element binding transcription factor 1
     evidenced by: QTL:13003; QTL:13004; QTL:13007; QTL:13010;
   • STAT5A: Signal transducer and activator of transcription 5A
     evidenced by: QTL:180982;
   • STAT6: Signal transducer and activator of transcription 6, interleukin-4 induced
     evidenced by: QTL:11479;
   • TBC1D16: TBC1 domain family member 16
     evidenced by: QTL:180985;
   • TG: Thyroglobulin
     evidenced by: QTL:153999; QTL:154000; QTL:28732;
   • TLL1: Tolloid like 1
     evidenced by: QTL:180987;
   • UCP3: Uncoupling protein 3 (mitochondrial, proton carrier)
     evidenced by: QTL:18457;
   • ZBED6: Zinc finger, BED-type containing 6
     evidenced by: QTL:36584; QTL:36595; QTL:36606;
   339 correlations are found involving Average daily gain